AU751571B2 - Snurpotine 1 human M3G-CAP specific nucleus import receptor protein with new domain structure, the production and use thereof - Google Patents

Snurpotine 1 human M3G-CAP specific nucleus import receptor protein with new domain structure, the production and use thereof Download PDF

Info

Publication number
AU751571B2
AU751571B2 AU49085/99A AU4908599A AU751571B2 AU 751571 B2 AU751571 B2 AU 751571B2 AU 49085/99 A AU49085/99 A AU 49085/99A AU 4908599 A AU4908599 A AU 4908599A AU 751571 B2 AU751571 B2 AU 751571B2
Authority
AU
Australia
Prior art keywords
nucleic acid
polypeptide
cap
allergies
snurportin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU49085/99A
Other languages
English (en)
Other versions
AU4908599A (en
Inventor
Jochen Huber
Christoph Huls
Reinhard Luhrmann
Claus Simandi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Research and Technologies GmbH and Co KG
Original Assignee
Aventis Research and Technologies GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Research and Technologies GmbH and Co KG filed Critical Aventis Research and Technologies GmbH and Co KG
Publication of AU4908599A publication Critical patent/AU4908599A/en
Application granted granted Critical
Publication of AU751571B2 publication Critical patent/AU751571B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Psychiatry (AREA)
  • Pulmonology (AREA)
  • Transplantation (AREA)
  • Emergency Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
AU49085/99A 1998-07-14 1999-07-07 Snurpotine 1 human M3G-CAP specific nucleus import receptor protein with new domain structure, the production and use thereof Ceased AU751571B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19831382 1998-07-14
DE19831382A DE19831382A1 (de) 1998-07-14 1998-07-14 Humanes m¶3¶G-cap-spezifisches Kernimportrezeptorprotein mit einer neuen Domänenstruktur, dessen Herstellung und Verwendung
PCT/EP1999/004750 WO2000004144A1 (de) 1998-07-14 1999-07-07 Snurportin 1, humanes m3g-cap-spezifisches kernimportrezeptorprotein mit einer neuen domänenstruktur, dessen herstellung und verwendung

Publications (2)

Publication Number Publication Date
AU4908599A AU4908599A (en) 2000-02-07
AU751571B2 true AU751571B2 (en) 2002-08-22

Family

ID=7873911

Family Applications (1)

Application Number Title Priority Date Filing Date
AU49085/99A Ceased AU751571B2 (en) 1998-07-14 1999-07-07 Snurpotine 1 human M3G-CAP specific nucleus import receptor protein with new domain structure, the production and use thereof

Country Status (6)

Country Link
EP (1) EP1097201A1 (de)
JP (1) JP2002520052A (de)
AU (1) AU751571B2 (de)
CA (1) CA2333895A1 (de)
DE (1) DE19831382A1 (de)
WO (1) WO2000004144A1 (de)

Also Published As

Publication number Publication date
WO2000004144A1 (de) 2000-01-27
JP2002520052A (ja) 2002-07-09
DE19831382A1 (de) 2000-02-03
AU4908599A (en) 2000-02-07
CA2333895A1 (en) 2000-01-27
EP1097201A1 (de) 2001-05-09

Similar Documents

Publication Publication Date Title
AU707598B2 (en) Cell death protein
Ohkuma et al. Structural motifs and potential a homologies in the large subunit of human general transcription factor TFIIE
Bunz et al. cDNAs encoding the large subunit of human replication factor C.
US6376661B1 (en) Human RNase H and compositions and uses thereof
JP3181660B2 (ja) ビリルビンオキシダーゼの製造法
CA2303760A1 (en) A potential effector for the grb7 family of signalling proteins
US6492168B1 (en) Methyltransferase gene and enzyme
AU751571B2 (en) Snurpotine 1 human M3G-CAP specific nucleus import receptor protein with new domain structure, the production and use thereof
KR102043356B1 (ko) 마크로포미나 파세올리나로부터의 리그닌 분해 효소 및 이의 용도
JP2001506850A (ja) 脂肪細胞特異的分化関連タンパク質
JP2003210183A (ja) ヒトＩκＢ−β
AU733462B2 (en) CYP7 promoter-binding factors
AU735512B2 (en) Modulators of BRAC1 activity
EP1007677B1 (de) Protease-ähnliches protein
JP4232423B2 (ja) 新規ユビキチン特異プロテアーゼ
US6919427B1 (en) Polypeptide-rna binding protein 33 and polynucleotide encoding said polypeptide
AU777034B2 (en) Human RNase H and compositions and uses therof
KR100191125B1 (ko) 마우스에서 분리한 신규의 swi3계 유전자 및 그로부터 발현되는 단백질
JP3243531B2 (ja) 機能性タンパク質のスクリーニング方法
US20030144496A1 (en) Human RNase H and compositions and uses thereof
JP2003159080A (ja) 痛みに関連する分子の同定及び使用
US6994996B1 (en) Polypeptide, human vacuolar H+ -ATPase C subunit 42 and polynucleotide encoding it
US6703201B1 (en) Human PEC-60-like protein and DNA encoding this protein
AU727305B2 (en) A potential effector for the GRB7 family of signalling proteins
US20040161762A1 (en) Novel human poly(a)polymerase gamma (pap gamma)

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)